[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Insider purchases increased stake in IRIDEX Corp. Romeo R. Dizon, the company's Chief Financial Officer, acquired a total of 1,000 shares of IRIDEX common stock on 08/22/2025 in three open-market transactions priced at $1.21, $1.22 and $1.23 per share. Following these purchases his reported beneficial ownership rose from 46,995 to 47,745 shares. The Form 4 was signed by an attorney-in-fact on 08/25/2025.

Positive

• Insider purchases totaling 1,000 shares on 08/22/2025, showing the CFO was a net buyer
• Clear disclosure of transaction dates, prices ($1.21, $1.22, $1.23) and resulting beneficial ownership (47,745 shares)

Negative

• None.

Insights

Securities Analyst

TL;DR: Company CFO made small open-market purchases totaling 1,000 IRIX shares, a routine insider buy with limited material impact.

The transactions consist of three purchases on 08/22/2025 at prices between $1.21 and $1.23, increasing reported beneficial ownership by 1,000 shares to 47,745. Given the absolute size and low per-share price, these transactions are routine and unlikely to be material for valuation or control; they do, however, signal the reporting insider was a net buyer on that date.

Corporate Governance Expert

TL;DR: Filing shows compliance with disclosure rules and a modest insider purchase by an executive.

The Form 4 is properly completed listing the reporter, role (CFO), transaction dates, quantities and prices. Total purchases are modest and disclosed as direct ownership increases. No derivative securities or additional arrangements are reported. From a governance standpoint, the filing meets Section 16 disclosure expectations without indicating material governance events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		P		250	A	$1.21	46,995	D
Common Stock	08/22/2025		P		500	A	$1.22	47,495	D
Common Stock	08/22/2025		P		250	A	$1.23	47,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for IRIX on this Form 4?

Romeo R. Dizon, CFO, reported three open-market purchases on 08/22/2025 totaling 1,000 shares at prices of $1.21, $1.22 and $1.23 per share.

How did the purchases change Romeo Dizon's beneficial ownership of IRIX?

Beneficial ownership increased from 46,995 shares before the transactions to 47,745 shares after the purchases.

Were any derivative securities or option exercises reported on this Form 4?

No. Table II for derivative securities contains no reported transactions; only non-derivative common stock purchases are listed.

When was the Form 4 signed and by whom?

The filing was signed on behalf of Romeo R. Dizon by an attorney-in-fact, Nilo De Castro, on 08/25/2025.